Tonsillar Metastasis of Small Cell Lung Cancer in a Patient With Idiopathic Pulmonary Fibrosis

AbstractSmall cell lung cancer (SCLC) metastasizes widely, but palatine tonsil is an extremely unusual site for metastasis. Idiopathic pulmonary fibrosis (IPF) is associated with increased risk of lung cancer. However, the most common histological findings among patients of lung cancer with IPF are known as non-SCLC such as adenocarcinoma and squamous cell carcinoma. In addition, the majority of them are located in IPF-associated fibrotic peripheral lesions.A 77-year-old man visited for 1-month persistent cough and dyspnea, with inspiratory dry crackles on both lower lung fields and a large oval mass in his throat. Chest computed tomography revealed 2 masses in the left lower lobe, 1 mass in the right upper lobe, and multiple enlarged mediastinal lymph nodes of the lung accompanying with IPF, which were diagnosed as SCLC pathologically. Very interestingly, the tonsillar mass was also confirmed as the metastatic lesion of SCLC. Chemotherapy for SCLC and medical treatment for IPF were applied. However, in following-up, he expired due to respiratory failure by an acute exacerbation of IPF 3 months after the diagnosis.In this current report, we describe, for the first time, a case of tonsillar metastasis of SCLC with IPF detected simultaneously in a 77-year-old man.

[1]  Vasilis Aidinis,et al.  Lung cancer in patients with idiopathic pulmonary fibrosis. , 2017, Pulmonary pharmacology & therapeutics.

[2]  A. Kurosaki,et al.  High-Resolution Computed Tomography Findings of Lung Cancer Associated With Idiopathic Pulmonary Fibrosis , 2006, Journal of computer assisted tomography.

[3]  C. Bilgen,et al.  An unusual tonsillolith. , 2003, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[4]  D. Spandidos,et al.  MYCL1, FHIT, SPARC, p16INK4 and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis , 2002, Journal of cellular and molecular medicine.

[5]  F. Bozza,et al.  [Palatine tonsillar metastasis from small cell carcinoma of the lung]. , 2000, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[6]  Y. Hisa,et al.  Small Cell Carcinoma of the Lung Metastatic to the Palatine Tonsil , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[7]  J. Im,et al.  Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. , 1996, Journal of computer assisted tomography.

[8]  Y. Mizushima,et al.  Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis. A review of Japanese cases. , 1995, Chest.

[9]  A. Nagai,et al.  Lung cancer in patients with idiopathic pulmonary fibrosis. , 1992, The Tohoku journal of experimental medicine.

[10]  D. Seddon Tonsillar Metastasis at Presentation of Small Cell Carcinoma of the Lung , 1989, Journal of the Royal Society of Medicine.

[11]  T. Kawai,et al.  DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AND LUNG CANCER , 1987, Acta pathologica japonica.

[12]  J. Elidan,et al.  A large tonsillolith simulating tumor of the tonsil. , 1980, Ear, nose, & throat journal.

[13]  W. Jaques,et al.  Hypernephroma Metastatic to the Palatine Tonsils , 1979, The Annals of otology, rhinology, and laryngology.

[14]  S. Yüksel,et al.  Tonsillar metastasis from small cell lung cancer: Rare but occurs , 2009 .

[15]  R. Enck,et al.  Lung cancer: diagnosis and management. , 2007, American family physician.

[16]  R. Hubbard,et al.  Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. , 2000, American journal of respiratory and critical care medicine.

[17]  J. Samet Does idiopathic pulmonary fibrosis increase lung cancer risk? , 2000, American journal of respiratory and critical care medicine.

[18]  D. Damm,et al.  Oral Pathology , 2020, Current Topics in Pathology.

[19]  L. Einhorn,et al.  Small cell carcinoma of the lung. , 1986, Critical reviews in oncology/hematology.